Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity
- 9 April 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (17), 2999-3007
- https://doi.org/10.1016/j.vaccine.2010.02.006
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based ImmunogensStructure, 2009
- Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitopeVirology, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only VaccinationJournal of Virology, 2008
- Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza virusesVaccine, 2008
- Replicating and non-replicating viral vectors for vaccine developmentCurrent Opinion in Biotechnology, 2007
- A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Virology, 2007
- Broad HIV-1 neutralization mediated by CD4-binding site antibodiesNature Medicine, 2007
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007
- Antibody Responses Elicited in Macaques Immunized with Human Immunodeficiency Virus Type 1 (HIV-1) SF162-Derived gp140 Envelope Immunogens: Comparison with Those Elicited during Homologous Simian/Human Immunodeficiency Virus SHIVSF162P4and Heterologous HIV-1 InfectionJournal of Virology, 2006